Hold
Contrarian Sentiment Indicator
In the past, converging positive and negative posts on this board have been good intermediate term contrarian indictors. On this basis, postings now are flashing a buy. Against longs, gene therapy stocks whose managements have been able to execute have had great run ups and look toppy, creating an industry headwind should SGMO deliver some good news over coming months. As I've posted before, SGMO board ought to explore selling the company to a larger firm with a better record of execution and with the capital to simultaneously run more multiple trials for target diseases. I have little doubt now that gene therapy will be a financial monster. SGMO board is probably aware now that winners could well be second best technology first over the finish line.